18+ · Research use only
Thymosin Alpha-1 Philippines
Thymosin Alpha-1 is a peptide sold by Primara Labs for research use only. It sells as a 10 pack at ₱2,376 a vial; a single vial is ₱3,890 on request. Metro Manila orders before 12 noon arrive the same day; provinces take 1 to 2 days Luzon, 2 to 3 Visayas, 3 to 5 Mindanao. Lab testing: no report published yet, scheduled, see primaralabs.com/coa.
Peptide studied in Phase 3 human trials. Lyophilized powder, stocked in Metro Manila and sold in 10 packs. For laboratory research use only.
Sold as a 10 pack
Pack price replaces the 10% off. One compound per pack.
Pack price replaces the standing 10% off; they don't stack. One compound per pack.
Single vial ₱3,890, on request
Request a single vialCheck out once for the whole cart. Pay by QR, confirm on WhatsApp.
Add more compounds if you like, then check out once. You pay by QR on your order page and send the screenshot on WhatsApp.
In the Philippines
GCash · Maya · QR Ph bank transfer · InstaPay
From abroad
- International transfer
Wise · International bank transfer · Zelle · Crypto
Payment details are sent in the WhatsApp chat once your order is confirmed.
Order by 12 noon on a weekday for same-day Metro Manila
Includes water, syringes, pads · plain box
60-day money-back guaranteeTerms
Order by 12 noon on a weekday for same-day delivery in Metro Manila
Free courier nationwide · Luzon 1-2 days · Visayas 2-3 days · Mindanao 3-5 days
Everything to reconstitute is included
10 x 3ml water · 100 syringes · 100 pads · plain outer packaging
60-day money-back guarantee
If an accredited independent laboratory reports that this vial is not the compound on the label, we refund what you paid for it. Evidence within 60 calendar days of delivery; you do not send anything back. Terms
Delivery proof
Real orders, really delivered

Metro Manila · Same-day
Shipped 1:57 PM, received 2:33 PM. Same day, 36 minutes.

Metro Manila · Customer reply
"Surprised din po ako. Magoorder ako ulit kapag naubos na." They came back and reordered.

Quezon City · Repeat customer
Delivered 11:34 PM. Three weeks later: "Can I order again." "Primara I can say was the best choice."
Real WhatsApp and courier screenshots. Names, numbers and addresses are blacked out.
Updated 16 November 2026
- Human evidence
- Phase 3
- Manufacturing
- cGMP · ISO 9001 · ISO 13485
- Latest batch report
- Scheduled, see /coa
- Storage
- 2 to 8 °C sealed
Thymosin Alpha-1 in the Philippines
Thymosin alpha-1, also called thymalfasin, is a 28-amino-acid peptide first isolated from the thymus. Reviews describe it acting on T cells, dendritic cells and natural killer cells, partly through Toll-like receptor signalling. It is approved as a prescription medicine in several countries, mainly in Asia, for chronic hepatitis B, but not in the United States.
Its largest trial was negative: TESTS, a phase 3 placebo-controlled trial in adults with sepsis, found no clear evidence that it reduced 28-day mortality, with similar adverse event rates in both groups. Smaller trials in hepatitis B, pooled in a meta-analysis, reported better response when it was added to lamivudine. The figures and sources are in the research section below.
Thymosin Alpha-1 is sold in 10 packs of 10mg vials. It arrives as a white lyophilised cake; refrigerate it at 2 to 8°C and keep it out of sunlight. Pay for the pack through the cart or settle it in a WhatsApp thread. Outside Metro Manila, courier delivery reaches Luzon in 1 to 2 business days, the Visayas in 2 to 3 and Mindanao in 3 to 5. The compounds we keep in stock are introduced in the philippinespeptides.com overview pages.
Regulatory status
Thymosin Alpha-1. FDA Philippines: not established. US FDA: Not approved. Checked 16 November 2026.
Sold for laboratory research only, not for human consumption. Primara Labs does not give medical advice or dosing guidance. Regulatory Status Tracker
Laboratory handling
Reconstitution reference
| BAC water added | Resulting concentration | Note |
|---|---|---|
| 1.0 ml | 10 mg/ml | Highest concentration, smallest volumes |
| 2.0 ml | 5 mg/ml | Common reference dilution |
Reconstitute with bacteriostatic water. Reference values are for laboratory preparation only. Other volumes: reconstitution calculator, prefilled for Thymosin Alpha-1 10mg.
Handling and storage
Sealed vials
Store sealed lyophilised vials refrigerated at 2 to 8 °C, away from light.
Primara Labs storage instructionAdding diluent
Add the diluent slowly down the inside wall of the vial rather than straight onto the powder.
Mixing
The US prescribing instructions for tesamorelin, a lyophilised peptide medicine, tell users to swirl the vial to mix the powder and liquid, and not to shake it.
Tesamorelin US instructions for use, DailyMed · checked 23 September 2026Appearance
The same instructions say not to use the solution if it is cloudy, discoloured or has particles in it.
Tesamorelin US instructions for use, DailyMed · checked 23 September 2026After the stopper is punctured
CDC guidance, citing USP chapter 797, is that a multi-dose vial once opened is dated and discarded within 28 days unless the manufacturer states another date, and never used past its original expiry.
CDC, Preventing Unsafe Injection Practices · checked 23 September 2026Benefits studied
Survival in adult sepsis (not shown)
Phase 3 humanIn TESTS, a phase 3 placebo-controlled trial in 1,106 adults with sepsis at 22 centres in China, 28-day all-cause mortality was 23.4% with thymosin alpha-1 and 24.1% with placebo, and the authors found no clear evidence that it reduces 28-day mortality.
Wu J et al. BMJ 2025 (TESTS), PubMed 39814420 · checked 16 November 2026Response in chronic hepatitis B
Small human studiesA 2009 meta-analysis of eight small trials in 583 people with HBeAg-positive chronic hepatitis B found higher rates of ALT normalisation, viral response and HBeAg seroconversion when thymosin alpha-1 was added to lamivudine than with lamivudine alone; the authors noted the trials were small.
Zhang YY et al. Virol J 2009 · checked 16 November 2026Recovery in hospitalised COVID-19 (not shown)
Small human studiesIn an open-label randomised pilot trial in 49 hospitalised adults with COVID-19, low oxygen and low lymphocyte counts, clinical recovery was higher with thymalfasin than with standard care but the difference was not statistically significant.
Shehadeh F et al. J Infect Dis 2023, PubMed 36056913 · checked 16 November 2026
Side effects reported
In the TESTS sepsis trial, adverse events occurred in 66.4% of patients given thymosin alpha-1 and 67.6% given placebo.
Wu J et al. BMJ 2025 (TESTS), PubMed 39814420 · checked 16 November 2026In the COVID-19 pilot trial, nine serious adverse events in treated patients were judged unrelated to thymalfasin, and the authors described the safety data as preliminary.
Shehadeh F et al. J Infect Dis 2023, PubMed 36056913 · checked 16 November 2026Findings are described as the research reported them, with the level of evidence for each. They are not a claim about any vial sold here, which is supplied for laboratory research use only.
How it works
Thymosin alpha-1, also called thymalfasin, is a 28-amino-acid peptide first isolated from the thymus. Reviews describe it acting on immune cells, including T cells, dendritic cells and natural killer cells, partly through Toll-like receptor signalling.
Targets: T cells, dendritic cells and natural killer cells, partly through Toll-like receptor signalling
What the research shows
Thymosin alpha-1 is a 28-amino-acid immune peptide, approved as a medicine in several countries, mainly in Asia, for chronic hepatitis B, but not in the United States. In the phase 3 TESTS trial of 1,106 adults with sepsis it did not reduce 28-day mortality compared with placebo, and adverse event rates were similar between groups. Small trials pooled in a 2009 meta-analysis suggested better response in hepatitis B when it was added to lamivudine.
Lab report: scheduled, see primaralabs.com/coa. No batch report for Thymosin Alpha-1 is published yet.
- Type
- Thymic peptide, 28 amino acids
- Presentation
- Lyophilized powder, 10 mg / vial
- Vial size
- 10mg
- Catalogue code
- PRM-027
PubChem could not be reached when this SKU was added on 16 November 2026, so no formula, weight or CAS is published from it yet.
Frequently asked
Thymosin Alpha-1 questions, answered
How much is Thymosin Alpha-1 in the Philippines?
At Primara Labs, Thymosin Alpha-1 10mg sells as a 10 pack at ₱2,376 per vial (₱23,760 total). A single vial is ₱3,890, available on request on WhatsApp. Prices are in pesos and the pack price is shown on the product page before you order.
Where can I buy Thymosin Alpha-1 in the Philippines?
Primara Labs sells Thymosin Alpha-1 10mg as a 10 pack, with single vials on request on WhatsApp. Two ways to order: add to cart and pay by QR (GCash, Maya, QR Ph, InstaPay), or message us on WhatsApp to pay by Wise, international bank transfer, Zelle or crypto.
Do you deliver Thymosin Alpha-1 to Cebu, Davao and the provinces?
Yes. Metro Manila: same day before 12 noon, Grab Express / Lalamove, ₱150; Luzon: 1 to 2 business days, J&T Express, ₱250; Visayas: 2 to 3 business days, J&T Express, ₱250; Mindanao: 3 to 5 business days, J&T Express, ₱300. Cebu is in the Visayas and Davao in Mindanao. Courier is free on orders over ₱10,000 anywhere in the Philippines. Below that, a Metro Manila rider is ₱150, J&T Express is ₱250 to Luzon and the Visayas and ₱300 to Mindanao.
Is Thymosin Alpha-1 FDA approved in the Philippines?
Thymosin Alpha-1. FDA Philippines: not established. US FDA: Not approved. Checked 16 November 2026. Primara Labs supplies it for research use only; it is not for human consumption.
Why is this sold as a 10-pack?
Thymosin Alpha-1 is sold in 10-packs, at ₱2,376 per vial. Single vials are available on request via WhatsApp at ₱3,890. Delivery times are the same as for the rest of the catalogue.
Is thymosin alpha-1 the same as thymalfasin?
Yes. Thymalfasin is the international name for synthetic thymosin alpha-1, the same 28-amino-acid peptide. Where it is approved as a medicine, the approval covers that registered product only, not a vial sold for research use.
What is Thymosin Alpha-1 studied for?
Thymosin alpha-1 is a 28-amino-acid immune peptide, approved as a medicine in several countries, mainly in Asia, for chronic hepatitis B, but not in the United States. In the phase 3 TESTS trial of 1,106 adults with sepsis it did not reduce 28-day mortality compared with placebo, and adverse event rates were similar between groups. Small trials pooled in a 2009 meta-analysis suggested better response in hepatitis B when it was added to lamivudine.
What side effects were reported for Thymosin Alpha-1?
In the TESTS sepsis trial, adverse events occurred in 66.4% of patients given thymosin alpha-1 and 67.6% given placebo. In the COVID-19 pilot trial, nine serious adverse events in treated patients were judged unrelated to thymalfasin, and the authors described the safety data as preliminary.
How should Thymosin Alpha-1 be stored?
Store sealed lyophilised vials refrigerated at 2 to 8 °C, away from light. CDC guidance, citing USP chapter 797, is that a multi-dose vial once opened is dated and discarded within 28 days unless the manufacturer states another date, and never used past its original expiry.
Does Primara Labs publish lab reports for Thymosin Alpha-1?
Lab report: scheduled, see primaralabs.com/coa. No batch report for Thymosin Alpha-1 is published yet.
All compounds supplied by Primara Labs are for laboratory research use only and are not for human consumption, diagnostic or therapeutic use. Statements on this page describe published research and have not been evaluated by the Philippine FDA. See Research Use Only terms.
